LOIS M RAMONDETTA to Mixed Tumor, Mullerian
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Mixed Tumor, Mullerian.
Connection Strength
0.282
-
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
Score: 0.224
-
Malignant mixed M?llerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):786-96.
Score: 0.058